Effect of modified ultrafiltration on bivalirudin elimination and postoperative blood loss after on-pump coronary artery bypass grafting: Assessment of different filtration strategies

Journal of Cardiac Surgery

Volumn 23, Issue 6, 2008, Pages 655-658

  Koster, Andreas ^a   Buz, Semih ^a   Krabatsch, Thomas ^a   Dehmel, Frank ^a   Kuppe, Hermann ^a   Hetzer, Roland ^a   Aronson, Solomon ^b   Dyke, Cornelius M ^c  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c Gaston Memorial Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIRULOG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HEMOFILTRATION; HUMAN; MALE; POSTOPERATIVE HEMORRHAGE; ULTRAFILTRATION;

ANTICOAGULANTS; CORONARY ARTERY BYPASS; FEMALE; HEMODIAFILTRATION; HIRUDINS; HUMANS; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PEPTIDE FRAGMENTS; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 55149083967     PISSN: 08860440     EISSN: 15408191     Source Type: Journal    
DOI: 10.1111/j.1540-8191.2008.00692.x     Document Type: Article

References (10)

1. Koster A, Dyke CM, Aldea G, et al : Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: Results of the CHOOSE-ON trial. Ann Thorac Surg 2007 83 : 572 577.
2. Chew DP : Bivalirudin, a bivalent thrombin specific anticoagulant as an alternative to heparin in interventional procedures. Hämostaseolgie 2002 22 : 142 148.
3. Koster A, Chew DP, Gründel M, et al : An assessment of different filter systems for extracorporeal elimination of bivalirudin. An in vitro study. Anesth Analg 2003 96 : 1316 1319.
4. Koster A, Spiess BD, Chew DP, et al : Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting. Am J Cardiol 2004 93 : 356 359.
5. Dyke CM, Smedira NG, Koster A, et al : A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: The EVOLUTION-ON study. J Thorac Cardiovasc Surg 2006 131 : 533 539.
6. Koster A, Dyke CM, Aldea G, et al : Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: Results of the CHOOSE-ON trial. Ann Thorac Surg 2007 83 : 572 577.
7. Koster A, Yeter R, Buz S, et al : Assessment of hemostatic activation during cardiopulmonary bypass for coronary artery bypass grafting with bivalirudin: Results of a pilot study. J Thorac Cardiovasc Surg 2005 129 : 1391 1394.
8. Koster A, Böttcher W, Merkel F, et al : The more closed the bypass system the better: A pilot study on the effects of reduction of cardiotomy suction and passive venting on hemostatic activation during on-pump coronary artery bypass grafting. Perfusion 2005 20 (5 285 288.
9. Ronco C, Cruz D : Hemodiafiltration history, technology, and clinical results. Adv Chronic Kidney Dis 2007 14 : 231 243.
10. Golper TA, Kaplan AA, Narasimhan N, et al : Transmembrane pressures generated by filtrate line suction maneuvers and predilution fluid replacement during in vitro continuous arteriovenous hemofiltration. Int J Artif Organs 1987 10 : 41 46.